U.S. Healthtech Stock News

Morningstar (MORN) has wrapped up FY 2025 with fourth quarter total revenue of US$641.1 million and basic EPS of US$2.84, capping a year where trailing twelve month revenue reached US$2.4 billion and EPS came in at US$8.93. Over the past few quarters, the company has seen quarterly revenue move from US$581.9 million in Q1 2025 to US$641.1 million in Q4, while basic EPS stepped from US$1.83 to US$2.84 over the same stretch, supported by earnings growth of 15.2% over the last year and net...

Bright Horizons Family Solutions (BFAM) has put fresh numbers on the table for FY 2025, with Q4 revenue of US$733.7 million and basic EPS of US$0.39. Trailing 12 month revenue sits at about US$2.9 billion against EPS of US$3.39. Over recent quarters, revenue has ranged from US$665.5 million to US$802.8 million as basic EPS moved between US$0.66 and US$1.38. Trailing 12 month net income rose from US$140.2 million to US$193.1 million, giving investors a clearer read on how margins are shaping...

On February 11, 2026, First Interstate BancSystem, Inc. presented at the KBW 2026 Winter Financial Services Conference at The Boca Raton in Florida, highlighting its current positioning to the financial services investment community. Despite concerns about modest longer-term revenue trends and profitability metrics, the bank has recently benefited from upward earnings estimate revisions and favorable analyst rankings that point to strong near-term momentum. Building on this, we’ll explore...

Elastic (NYSE:ESTC) has rolled out Elastic Inference Service for self-managed Elasticsearch customers, giving them access to cloud-hosted GPU inference and Jina Rerankers without running their own GPU hardware or overhauling existing architectures. See our latest analysis for Elastic. Despite the new AI focused launches, Elastic’s recent share price returns have been mixed. The 30 day share price return is 15.03% and the 90 day share price return is 32.21%, while the 1 year total shareholder...

If you are looking at Whirlpool and wondering whether the current share price reflects its true worth, this article will walk through what the numbers are saying about value. The stock recently closed at US$88.69, with returns of 2.5% over 7 days, 4.0% over 30 days, 19.0% year to date and a 9.3% decline over the past year, alongside 26.5% and 41.7% declines over 3 and 5 years respectively. Recent news coverage around Whirlpool has focused on its position in the home appliances market and how...

Welltower (WELL) has quickly moved onto investors' radar after reporting robust 2025 revenue and EBITDA growth, issuing upbeat 2026 guidance for net income and funds from operations, and reaffirming its long-running quarterly dividend. See our latest analysis for Welltower. That earnings beat and upbeat 2026 funds from operations guidance have gone hand in hand with stronger trading, with a 7 day share price return of 7.55% and a 30 day share price return of 11.66%, while the 1 year total...

Chubb (CB) is back in focus after reporting fourth quarter net income of US$3.21b and full year net income of US$10.31b. Management pointed to strong insurance operations and record investment income. See our latest analysis for Chubb. The earnings beat and recent buyback activity come after a strong run, with a 30 day share price return of 7.95% and a 1 year total shareholder return of 24.47% signalling momentum that has built gradually over several years, including a 5 year total...

Evolution Petroleum (EPM) just posted Q2 2026 results with revenue of US$20.7 million, basic EPS of US$0.03 and net income of US$1.0 million, set against trailing 12 month revenue of US$85.6 million and basic EPS of US$0.08. Over the last year, revenue has been running in the US$85 million range while net income on a trailing basis has moved to US$2.7 million, giving investors a clearer picture of how recent quarters are feeding into the longer term earnings line. With net margin at 3.2% over...

Madison Square Garden Sports Corp. has reported past second-quarter 2026 results showing sales of US$403.42 million and net income of US$8.24 million, alongside the completion of a long-running US$340.33 million share repurchase program that retired 2,018,458 shares since it began in 2015. At the same time, the extended digital innovation partnership across the MSG Family of Companies with Infosys, including the renaming of the 5,600-seat Infosys Theater at Madison Square Garden, underlines...

Four Corners Property Trust (FCPT) has wrapped up FY 2025 with fourth quarter total revenue of US$75.7 million, basic EPS of US$0.28 and funds from operations of US$45.7 million, giving investors a fresh look at the REIT's cash generation. Over the past six quarters, the company has seen total revenue move from US$66.8 million in Q3 2024 to US$75.7 million in Q4 2025. Trailing twelve month revenue sits at US$294.1 million and EPS at US$1.09, framing the latest results for income-focused...

Williams Companies (NYSE:WMB) has completed a series of major pipeline and offshore projects and formed a new partnership with Woodside Energy. The company has launched ten new initiatives across pipeline transmission, gathering, storage, and power-related projects. Williams has sold its Haynesville E&P business and outlined substantial new growth capital commitments. The company has also announced a 5% dividend increase alongside its latest expansion plans. For investors watching NYSE:WMB,...

The sharp move in Hims & Hers Health (HIMS) has centered on mounting legal and regulatory pressure, including Novo Nordisk’s patent lawsuit over compounded semaglutide products, FDA scrutiny of compounding practices, and a Department of Justice referral. See our latest analysis for Hims & Hers Health. At a share price of $16.30, Hims & Hers Health has experienced a sharp reset, with a 7 day share price return of 29.19% and a 30 day share price return of 47.96%. The 1 year total shareholder...

Alexander's (ALX) is back in focus after its latest earnings release, where fourth quarter results came in below analyst expectations and both revenue and net income declined compared with the prior year period. See our latest analysis for Alexander's. The recent earnings miss and weaker profitability seem to have weighed on sentiment, with a 7 day share price return of negative 8.31%. However, the 90 day share price return of 8.01% and 1 year total shareholder return of 24.14% suggest longer...

MVB Financial (MVBF) has wrapped up FY 2025 with fourth quarter revenue of US$36.9 million and basic EPS of US$0.33, set against trailing twelve month revenue of US$158.9 million and EPS of US$2.11 that frame the full year earnings picture. Over recent periods, the company has seen quarterly revenue move between US$31.7 million and US$56.8 million, while basic EPS has ranged from US$0.16 to US$1.36, giving investors a wide band of outcomes to weigh as they assess the latest print. With a...

Caterpillar recently reported strong fourth-quarter 2025 results, with revenue and adjusted earnings surpassing expectations as its power and energy segment, supported by AI-driven data center demand, became its largest business by revenue and helped build a record US$51.00 billion backlog. The company’s growing role in supplying power infrastructure for AI data centers and large-scale construction, particularly in markets like India and Latin America, is reshaping how investors view this...

Bio-Rad Laboratories (BIO) has put up a mixed set of numbers for Q3 FY 2025, with revenue of US$653 million and a basic EPS loss of US$12.70, against a backdrop of prior quarters that ranged from EPS of US$23.37 on US$649.7 million of revenue in Q3 FY 2024 to a loss of US$25.57 on US$667.48 million of revenue in Q4 FY 2024. Over the past few quarters, revenue has generally sat in the US$585 million to US$667 million band, while EPS has swung sharply between gains and losses. Investors will...

Centessa Pharmaceuticals (CNTA) has drawn fresh attention after outlining 2026 plans for its orexin pipeline, including moving lead asset ORX750 toward registrational studies and advancing ORX142 into clinical trials, while also preparing for a pre-commercial shift. See our latest analysis for Centessa Pharmaceuticals. The recent orexin updates come after a mixed price pattern, with a 1 month share price return of 11.86% and a 3 month share price return decline of 10.5%. However, the 3 year...

BridgeBio Pharma recently reported positive topline results from PROPEL 3, its global Phase 3 trial of oral infigratinib in children with achondroplasia, showing statistically significant gains in annualized height velocity, improved body proportionality in younger children, and a favorable tolerability profile with no serious drug-related adverse events. An interesting aspect of the data is that infigratinib delivered the highest absolute annualized height velocity and height Z-score...

Lincoln Electric Holdings (LECO) has wrapped up FY 2025 with Q4 revenue of US$1,078.7 million and basic EPS of US$2.48, while trailing twelve month revenue came in at US$4.2 billion with EPS of US$9.39. Over the past six quarters in the data set, revenue has ranged from US$983.8 million to US$1,088.7 million per quarter and quarterly EPS has moved between US$1.78 and US$2.58, giving you a clear view of how the top and bottom lines have been tracking into this latest print. With net profit...

In the past week, Harley-Davidson reported fourth-quarter 2025 results showing a net loss of US$279.3 million and a basic loss per share of US$2.44, alongside weaker full-year profitability and a completed US$500.72 million share buyback that retired 16,576,158 shares. At the same time, management framed 2026 as a transition year focused on resetting dealer inventory and profitability, while S&P Global Ratings warned its investment-grade credit rating could be cut to junk pending a new...

If you are wondering whether Baker Hughes is still worth considering at current levels, the key question is how its price compares with its underlying value. The stock last closed at US$61.20, with returns of 3.9% over 7 days, 22.4% over 30 days, 29.8% year to date, 34.1% over 1 year, 113.5% over 3 years and 194.8% over 5 years. This naturally raises questions about what is already priced in and how perceptions of risk may have shifted. Recent headlines have focused on Baker Hughes' role in...

Alibaba Group Holding (NYSE:BABA) was briefly added to a US Pentagon list of companies alleged to support the Chinese military, before the designation was withdrawn the same day. The episode raises questions about potential regulatory and reputational pressure for Alibaba’s international operations, even without immediate legal restrictions. This comes as Alibaba steps up its global AI efforts, including its open source RynnBrain model and new partnerships. For investors watching NYSE:BABA,...

Twilio (TWLO) closed FY 2025 with fourth quarter revenue of US$1.37b and basic EPS of a US$0.30 loss, as net income excluding extra items came in at a loss of US$45.85m. Across the year, the company has seen quarterly revenue move from US$1.17b in Q1 to US$1.37b in Q4. Basic EPS ranged from US$0.13 in Q1 to US$0.24 in Q3, before swinging back to a loss in the final quarter. This sets up a mixed but margin-focused story for investors to unpack. See our full analysis for Twilio. With the...

Essential Properties Realty Trust (EPRT) just posted its FY 2025 numbers with fourth quarter revenue of US$149.9 million, basic EPS of US$0.34 and funds from operations of US$108.9 million, giving investors a fresh read on its income producing portfolio. The company has seen quarterly revenue move from US$119.7 million in Q4 2024 to US$149.9 million in Q4 2025, while basic EPS went from US$0.31 to US$0.34 over the same period, with FFO per share stepping from US$0.49 in Q3 2024 to US$0.54 in...